New vanadium complexes
US5278154A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 31, 1992 |
| Grant date | Jan 11, 1994 |
| Priority date | — |
| Expiry date | Dec 31, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I): ##STR1## in which: R.sub.1 or R.sub.4, which are identical or different, represent hydrogen or alkyl, PA1 R.sub.2 represents hydrogenm or alkyl, hydroxymethyl, --CH.sub.2 OPO(OH).sub.2 or --CH.sub.2 OPO(ONa).sub.2, PA1 R.sub.3 represents hydrogen, alkyl or hydroxyl or any one of the following groups: ##STR2## in which: T represents oxygen or sulfur, PA2 n represents an integer between 1 and 4, PA2 R.sub.5 represents hydrogen or alkyl, PA1 X represents nitrogen, CH or CR'.sub.3 (in which R'.sub.3 has the same meaning as R.sub.3 except in the case where R.sub.3 represents hydroxyl), PA1 A represents alkylene of formula --(CH.sub.2).sub.p --in which p represents an integer between 2 and 4, optionally substituted by one or more linear or branched (C.sub.1 -C.sub.4) alkyl, or any one of the following radicals: ##STR3## Y and Z together form oxygen or simultaneously represent two hydroxyl and in this case, the compound of formula (I) is positively charged, their isomers as well as their addition salts with a pharmaceutically acceptable acid or base. Medicinal products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.